Physician profile
Jordan E Alger
NPI 1851786065
$3,548.54
in general payments reported to CMS, 2019-2025
25 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $618 · 2022: $766 · 2023: $323 · 2024: $431 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441 · Travel and Lodging: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.42 |
| Travel and Lodging | $722.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $895.48 | 2021-2025 | Lumenis Pulse 120h, Lithovue, Rezum Generator |
| Procept Biorobotics Corporation | $772.63 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Verathon INC. | $400.00 | 2021 | |
| Dendreon Pharmaceuticals LLC | $190.10 | 2021-2024 | Provenge |
| Valencia Technologies Corporation | $139.83 | 2024-2025 | Ecoin Device Kit |
| Progenics Pharmaceuticals, INC. | $138.32 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $106.81 | 2022-2025 | Welireg, Keytruda, Lynparza |
| 180 Medical, INC. | $97.10 | 2023-2025 | Cure Catheter |
| Myovant Sciences INC. | $92.07 | 2021-2022 | |
| Olympus America INC. | $86.12 | 2025 | Itind System |
| Amgen INC. | $85.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.15 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $70.48 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $67.87 | 2022-2025 | Xtandi |
| Abbvie INC. | $52.68 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $46.14 | 2021-2023 | Urolift |
| Pfizer INC. | $43.35 | 2025 | |
| Janssen Biotech, INC. | $42.22 | 2021-2024 | Erleada |
| Laborie Medical Technologies Corp. | $37.42 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $26.98 | 2023 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $24.29 | 2022 | |
| Accord Healthcare, INC. | $19.98 | 2025 | |
| Tolmar, INC. | $16.53 | 2024 | |
| Urogen Pharma, INC. | $15.99 | 2023 | Jelmyto |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Alger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.